Equities

POINT Biopharma Global Inc

PNT:NAQ

POINT Biopharma Global Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)7.22
  • Today's Change0.06 / 0.84%
  • Shares traded1.04m
  • 1 Year change+18.17%
  • Beta--
Data delayed at least 15 minutes, as of Jan 26 2023 21:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • PNT:NAQ price moved over -1.54% to 7.02
  • PNT:NAQ trading volume exceeds daily average by +25.68%
  • PNT:NAQ price falls below 50-day moving average to 6.96 at 09:30 GMT
  • PNT:NAQ price falls below 50-day moving average to 6.97 at 09:46 GMT
  • PNT:NAQ price rises above 15-day moving average to 7.30 at 09:34 GMT
  • PNT:NAQ price rises above 15-day moving average to 7.30 at 15:12 GMT

Key statistics

On Thursday, POINT Biopharma Global Inc (PNT:NAQ) closed at 7.22, 38.18% above the 52 week low of 5.23 set on Mar 09, 2022.
52-week range
Today
5.23Mar 09 202210.98Sep 12 2022
Markit short selling activity
Low
Med
High
Open7.19
High7.26
Low6.93
Bid6.92
Offer7.51
Previous close7.16
Average volume523.54k
Shares outstanding105.64m
Free float89.46m
P/E (TTM)--
Market cap756.42m USD
EPS (TTM)-0.8713
USD
Data delayed at least 15 minutes, as of Jan 26 2023 21:00 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.